Species shift and multidrug resistance of<i>Campylobacter</i>from chicken and swine, China, 2008–14

Abstract

The high prevalence of fluoroquinolone and macrolide resistance in Campylobacter suggests that these two clinically important antibiotic classes may no longer be suitable for the treatment of human campylobacteriosis in China. Thus, enhanced surveillance and control efforts are needed to reduce antimicrobial resistance in this group of major foodborne pathogens.